Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

5 Fractions of Pelvic SABR With Intra Prostatic SABR

NCT02911636 is registered in ClinicalTrials.gov with Andrew Loblaw as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02911636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
5 Fractions of Pelvic SABR With Intra Prostatic SABR
Lead sponsor
Andrew Loblaw
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2016
Completion date
October 31, 2022
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer